Rare Mutations and What They Do
The second part of the research aimed to answer a key question about the genes discovered to be irregular: What were their functions? Were their functions similar or different in healthy people versus those with schizophrenia?
Here, too, the results were striking. In people with schizophrenia, almost half the time the disrupted genes were involved in pathways important in brain development, Dr. Sebat said. By contrast, when we looked at the set of genes that were disrupted in healthy people, we found that they were not overrepresented in any particular pathway.
In a paper that will first appear March 27 in the online edition of Science, the team notes that of 24 rare mutations seen in the schizophrenia group, 11, or 45 percent, affect cellular signaling pathways critical to neuronal cell growth, migration, proliferation, differentiation, apoptosis and synapse formation. Some of the affected pathways have turned up in past studies of schizophrenia, notably those involving signaling in neuregulin, a growth factor, and glutamate, a neurotransmitter.
Implications and Future Studies
While the study, as the scientists directly concede in their paper, does not prove the involvement with the illness of any specific variant, or even the involvement of any specific gene, it does, however, indicate a role for rare mutations that disrupt genes in pathways of neuronal development and regulation.
The results are powerful because they link specific structural variation in genes with specific functions known to be important in the early years of life, during which schizophrenia
'/>"/>
| Contact: Jim Bono pubaff@cshl.edu 516-367-8455 Cold Spring Harbor Laboratory Source:Eurekalert |